CorMedix prices $40M public offering of 7.5M shares at $4.00/sh and pre-funded warrants

CorMedix Inc.

Gross proceeds ~$40M from 7.5M shares at $4.00/sh and 2.5M pre-funded warrants at $3.999.
Underwriters granted 30-day option for up to 1.5M additional shares at $4.00/sh.
Net proceeds ~$37.3M (or ~$43M if option exercised); closing expected July 3, 2023.
Proceeds for general corporate, commercialization efforts, R&D, and working capital.
Offering via shelf S-3; RBC, Truist, JMP as book-running managers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.